Stay updated with breaking news from Foundation Fighting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IZERVAY is the only approved GA treatment with a statistically significant reduction in the rate of GA progression at the 12-month primary endpoint across two Phase 3 clinical trials IZERVAY slowed loss of photoreceptors
February 13, 1927 - July 25, 2023
Lobbying revenues at K Street’s top firms began to rebound from a slower start to 2023, as lawmakers set to work on a slew of must-pass bills.
/PRNewswire/ -- Hope in Focus, a nonprofit dedicated to finding treatments and cures for blindness caused by rare inherited retinal diseases, presents its 2023...
/PRNewswire/ -- The Foundation Fighting Blindness, the world's leading organization committed to finding treatments and cures for blinding retinal diseases,...